̽��ֱ�� of Cambridge - appointments

Professor Duncan Richards appointed as Head of Department of Medicine

Anonymous — Fri, 06 Dec 2024 16:59:07 +0000

Professor Richards joins Cambridge from the ̽��ֱ�� of Oxford, where he has been since 2019. His particular research interest is the demonstration of clinical proof of concept of novel therapeutics through the application of experimental medicine techniques, especially human challenge studies.

As Climax Professor of Clinical Therapeutics, director of the Oxford Clinical Trial Research Unit (OCTRU), and the NIHR Oxford Clinical Research Facility, he led a broad portfolio focused on new medicines for multiple conditions. His focus has been the acceleration of promising new drug treatments through better decision-making in early phase clinical trials.

Professor Richards also brings with him a wealth of experience in a number of Pharmaceutical R&D clinical development roles. In 2003 he joined GSK and held a number of roles of increasing responsibility, latterly as Head of Clinical Pharmacology and Experimental Medicine, including directorship of GSK’s phase 1 and experimental medicine unit in Cambridge (CUC).

Commenting on his appointment, Professor Richards said: “As a clinical pharmacologist, I have been fortunate to work across a broad range of therapeutic areas over the years. I am excited by the breadth and depth of expertise within the Department of Medicine and look forward to working with the first-class scientific team. My goal is to work with the Department team, the Clinical School, and hospitals to maximise the impact of the important work taking place in Cambridge.”

Members of the department’s leadership team are looking forward to the continued development of the department under Professor Richards, building on its legacy of collaboration and groundbreaking translational research to drive our future success.

Professor Mark Wills, Interim Head of Department of Medicine, said: “Duncan brings to his new role a fantastic breadth of experience, which encompasses his clinical speciality in pharmacology, extensive experience of working within the pharmaceutical industry R&D at senior levels and most recently establishing academic clinical trials units and human challenge research facilities.

“I am very excited to welcome Duncan to the Department and looking forward to working with him, as he takes on the role of delivering of the Department of Medicine’s vision to increase the efficacy of translation of its world class fundamental research, and its impact upon clinical practice and patient wellbeing.”

Menna Clatworthy, Professor of Translational Immunology and Director of the Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), said: "Duncan has a wealth of leadership experience in biomedicine, in both academia and pharma. That skillset will be invaluable in ensuring the Department of Medicine continues to deliver world-leading research to transform patient outcomes."

Charlotte Summers, Professor of Intensive Care Medicine and Director of the Victor Phillip Dahdaleh Heart & Lung Research Institute, said: “Duncan’s exemplary track record of translating fundamental scientific discoveries into therapies that benefit patients will help us further increase the impact of our research as we continue our mission to improve human health.”

̽��ֱ��appointment underpins the recently announced five-year collaboration between GSK and the ̽��ֱ�� of Cambridge, the Cambridge-GSK Translational Immunology Collaboration (CG-TIC). ̽��ֱ��£50 million investment will accelerate research and development in kidney and respiratory diseases to improve patient outcomes.

Professor Richards will assume the role in February 2025, replacing Interim Head of Department Dr Mark Wills who was appointed after the departure of Professor Ken Smith in January 2024. Dr Wills will continue as Director of Research and Deputy Head of the Department of Medicine as well as leading his research group.

Professor Richards trained in medicine at Oxford ̽��ֱ�� and after junior doctor roles in London, he returned to Oxford as Clinical Lecturer in Clinical Pharmacology. His DM thesis research was on a translational model using platelet ion flux to interrogate angiotensin biology and he is author of the Oxford Handbook of Practical Drug Therapy and the 3rd edition of Drug Discovery and Development.

Professor Richards has been a core member of the UK COVID-19 Therapeutics Advisory Panel. He is a member of the Oxford Bioescalator Management Board, UK Prix Galien Prize Committee, and the therapeutic advisory committee of several national platform clinical trials.

Professor Duncan Richards has today been announced as the new Head of the Department of Medicine at the ̽��ֱ�� of Cambridge.

I am excited by the breadth and depth of expertise within the Department of Medicine and look forward to working with the first-class scientific team

Duncan Richards

̽��ֱ��text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright © ̽��ֱ�� of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

Yes

Professor Lynn Gladden named Executive Chair of Engineering and Physical Sciences Research Council

sc604 — Thu, 03 May 2018 08:58:51 +0000

Professor Gladden is currently Shell Professor of Chemical Engineering at the ̽��ֱ�� of Cambridge. She is internationally recognised for her work on magnetic resonance imaging (MRI) methods which have benefited a wide array of industrial processes and contributed to a range of products and process technologies across multiple sectors.

UK Research and Innovation (UKRI) is the main mechanism that promotes the UK’s strengths in research and innovation both at home and around the world and ensures that the UK continues to make the most of its world-leading R&D sector and provide support for researchers and scientists.

EPSRC is the UK’s main funder for research across the engineering and physical sciences. It supports excellent, long-term research and high-quality postgraduate training, in order to contribute to the economic competitiveness of the UK.

“EPSRC science delivers world-leading, original thinking in mathematics, physical sciences and engineering that transforms the world we live in, and I am honoured to have been selected to be its new Executive Chair,” said Professor Gladden. “This is an exciting time to lead EPSRC. In particular, the formation of UKRI offers opportunities for EPSRC science and thinking to expand into new fields through collaboration with partner Councils, and to explore new ways of working to deliver the UK’s Industrial Strategy.”

Sir Mark Walport, UKRI CEO, said: “Professor Lynn Gladden is a world-leading chemical engineer. Her ground-breaking work in academia coupled with her strong collaborations with industry makes her the ideal candidate to lead EPSRC and ensure the wider success of UK Research and Innovation.

Lynn will build on the successes of her predecessor, Professor Philip Nelson, who I would like to thank for his exceptional leadership of EPSRC over the last four years and the crucial role he has played in the creation of UK Research and Innovation.”

Professor Gladden is Shell Professor of Chemical Engineering in Cambridge’s Department of Chemical Engineering & Biotechnology, and a Fellow of Trinity College. Her research has focused on advancing magnetic resonance imaging techniques, originally developed for use in the medical environment, and using them in engineering research to gain a greater understanding of the physical and chemical phenomena that determine the performance of chemical processes and their resulting products. In addition to her own research, Professor Gladden has held a number of research oversight roles in the UK and abroad, including Pro-Vice-Chancellor for Research at Cambridge from 2010 to 2016. She is currently a Judge for the Queen Elizabeth Prize for Engineering.

Professor Lynn Gladden CBE, FRS, FREng has been selected to be the next Executive Chair of the Engineering and Physical Sciences Research Council (EPSRC), as announced today by Science Minister Sam Gyimah. She will take up the role in October, succeeding Professor Philip Nelson who will step down at the end of September.

Jason Alden/QEPrize

Lynn Gladden

̽��ֱ��text in this work is licensed under a Creative Commons Attribution 4.0 International License. For image use please see separate credits above.

Yes

Cambridge reveals identity of new ̽��ֱ�� Librarian

sjr81 — Fri, 09 Dec 2016 09:46:10 +0000

Dr Gardner is currently Director of Library Services and ̽��ֱ�� Librarian at the ̽��ֱ�� of Bristol, and will take up her new post at Cambridge in April 2017. She follows in the footsteps of Anne Jarvis, who was ̽��ֱ�� Librarian at Cambridge from 2009 until September 2016.

Dr Gardner said: “I am delighted to have been elected as Cambridge ̽��ֱ��’s Librarian and to have the opportunity to build on the success of a long line, over 600 years, of my predecessors, most recently the wonderful Anne Jarvis.

“It will be an honour to join Cambridge and to lead one of the world’s great research and copyright libraries, rich with world heritage treasures.”

This year (2016) marks the 600th anniversary of the first mention of Cambridge ̽��ֱ�� Library. Older than the British Library and the Vatican Library, it was first mentioned by name in two wills dated March 1416 – with its most valuable contents stored in a wooden chest. Today, the Library is home to eight million books, journals, maps and magazines, as well as some of the world’s most iconic scientific, literary and cultural treasures.

Its priceless collections include Newton’s own annotated copy of Principia Mathematica, Darwin’s papers on evolution, 3000-year-old Chinese oracle bones and the earliest reliable text for 20 of Shakespeare’s plays (First Folio).

Earlier this year, a spectacular exhibition, Lines of Thought, put on display some of the most valuable, rare and important books and artefacts in the collections, attracting record audiences and interest from around the world.

Since 1710, the Library has also been entitled to one copy of each and every publication in the UK and Ireland under Legal Deposit. With two million of its volumes on open display, readers have the largest open-access collection in Europe immediately available to them.

Cambridge ̽��ֱ�� Library’s current exhibition – Curious Objects – takes a sideways look at the 600-year-old institution, showcasing its collection of weird and wonderful non-book items such as ectoplasm and paintings from Pompeii.

Acting ̽��ֱ�� Librarian, Professor Chris Young, said: “Dr Jessica Gardner’s experience, knowledge, vision and warmth make her an exceptionally qualified candidate to lead Cambridge ̽��ֱ�� Library. It has been a privilege to steer this extraordinary institution through this time of transition, and I am delighted to know I will be handing over to someone as capable as Dr Gardner.

“In my role as Deputy Head of the School of Arts and Humanities, I look forward to working with her to create closer links between the treasures of Cambridge ̽��ֱ�� Library and the outstanding research happening across the ̽��ֱ��.”

Dr Gardner added “ ̽��ֱ��collections held by Cambridge span more than 4,000 years of recorded human thought. I’ll want to develop a shared vision with staff and students of the ̽��ֱ�� to help build the Library’s global profile for its leading role in collection, shaping, preserving and inspiring world knowledge.”

Dr Jessica Gardner has been revealed as the new Librarian of Cambridge ̽��ֱ�� Library – becoming the second female in the history of the institution to hold the role.

It will be an honour to join Cambridge and to lead one of the world’s great research and copyright libraries.

Jessica Gardner

Dr Jessica Gardner

̽��ֱ��text in this work is licensed under a Creative Commons Attribution 4.0 International License. For image use please see separate credits above.

Yes

Licence type:

Attribution-Noncommercial-ShareAlike

Cambridge appoints new development and alumni relations director

th288 — Mon, 11 Mar 2013 12:02:06 +0000

Alison Traub is currently Campaign Director for the ̽��ֱ�� of Virginia’s $3 billion campaign and Associate Vice-President for Development there.

She will join Cambridge on the back of the 800th Anniversary Campaign which was the first university fundraising drive outside the USA to raise more than £1 billion.

An international appointment reflecting the university’s formidable global reputation and performance, the Executive Director of Development and Alumni Relations will carry forward the philanthropic agenda to the next stage. This follows the recent decision by the ̽��ֱ�� to increase substantially its investment in development and alumni relations, including making preparations with the Colleges for the next Collegiate Cambridge Campaign.

Reporting directly to the Vice-Chancellor, Traub will work closely with senior ̽��ֱ�� and College academic and administrative leadership, staff and alumni.

̽��ֱ��Vice-Chancellor, Professor Sir Leszek Borysiewicz, said: “ ̽��ֱ��need for philanthropic funding to sustain Cambridge’s position as one of the best universities in the world has never been greater. To be a global leader in education and research requires Cambridge to continue to be a leader in philanthropy. Alison’s is an excellent appointment and we look forward to welcoming her to Cambridge at this time of significant opportunity for the Collegiate ̽��ֱ��.”

Alison Traub said: “It is an honour to join the ̽��ֱ�� at this exciting time as Cambridge charts a course for learning and discovery in the years to come.”

̽��ֱ��Cambridge ̽��ֱ�� Development and Alumni Relations Office has the responsibility for building lifelong relationships with the ̽��ֱ��’s alumni body as a whole, for raising major philanthropic gifts from alumni and non-alumni sources; and for communicating persuasively with all audiences to satisfy these objectives.

It works collaboratively with all members of collegiate Cambridge including the 31 colleges.

Alison Traub will take up her new role in June 2013

A senior higher education development executive with considerable experience in major campaigns has been appointed by the ̽��ֱ�� of Cambridge to lead its development and alumni relations programmes.

Alison’s is an excellent appointment and we look forward to welcoming her to Cambridge at this time of significant opportunity for the Collegiate ̽��ֱ��. 

̽��ֱ��Vice-Chancellor

This work is licensed under a Creative Commons Licence. If you use this content on your site please link back to this page.

Yes